Answers are grounded in this paper and cite their sources.
We used a method that combined literature review and expertjudgment to assess potential medical innovations for older adults. We evaluated innovations in four domains: cardiovascular disease, cancer, the biology of aging, and neurologic disease. The innovations can be categorized by common themes: improved disease prevention, better detection of subclinical or early clinical disease, and treatments for established disease. We report the likelihood, potential impact, and potential cost implications for thirty-four innovations, and we revisit this forecast five years later. Many of the innovations have the potential to greatly affect the costs and outcomes of health care.
No takes yet. Share an insight, caveat, or question.
Shekelle et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: